These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 34919024)
21. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis. Zhang W; Song C; Ren X Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909 [TBL] [Abstract][Full Text] [Related]
22. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072 [TBL] [Abstract][Full Text] [Related]
23. Circ_0011058 facilitates proliferation, angiogenesis and radioresistance in papillary thyroid cancer cells by positively regulating YAP1 via acting as miR-335-5p sponge. Zhang Z; Wang W; Su Z; Zhang J; Cao H Cell Signal; 2021 Dec; 88():110155. PubMed ID: 34562605 [TBL] [Abstract][Full Text] [Related]
24. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
25. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression. Li Y; Ma Z; Luo M; Liang R Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095 [TBL] [Abstract][Full Text] [Related]
26. Sevoflurane inhibits the malignant phenotypes of glioma through regulating miR-146b-5p/NFIB axis. Wang H; Cheng G; Quan L; Qu H; Yang A; Ye J; Feng Y; Li X; Shi X; Pan H Metab Brain Dis; 2022 Jun; 37(5):1373-1386. PubMed ID: 35386035 [TBL] [Abstract][Full Text] [Related]
28. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
29. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis. Zhang N; Fan J; Deng Z Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518 [TBL] [Abstract][Full Text] [Related]
30. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis. Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673 [TBL] [Abstract][Full Text] [Related]
31. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis. Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592 [TBL] [Abstract][Full Text] [Related]
32. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p. Zhang J; Mao J Histol Histopathol; 2023 Jun; 38(6):709-724. PubMed ID: 36416408 [TBL] [Abstract][Full Text] [Related]
33. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
34. Circular RNA CELF1 drives immunosuppression and anti-PD1 therapy resistance in non-small cell lung cancer via the miR-491-5p/EGFR axis. Ge W; Chi H; Tang H; Xu J; Wang J; Cai W; Ma H Aging (Albany NY); 2021 Nov; 13(22):24560-24579. PubMed ID: 34788230 [TBL] [Abstract][Full Text] [Related]
35. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5. Luo H; Peng J; Yuan Y Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822 [TBL] [Abstract][Full Text] [Related]
36. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis. Wu Y; Xie J; Wang H; Hou S; Feng J J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749 [TBL] [Abstract][Full Text] [Related]
37. Circular RNA circ_0002360 regulates the Taxol resistance and malignant behaviors of Taxol-resistant non-small cell lung cancer cells by microRNA-585-3p-dependent modulation of G protein regulated inducer of neurite outgrowth 1. Cui X; Zhang B; Li B; Li X Bioengineered; 2022 Apr; 13(4):9070-9085. PubMed ID: 35293280 [TBL] [Abstract][Full Text] [Related]
38. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2. Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230 [TBL] [Abstract][Full Text] [Related]
39. Circ_0110498 facilitates the cisplatin resistance of non-small cell lung cancer by mediating the miR-1287-5p/RBBP4 axis. Hao D; Li Y; Shi J; Jiang J Thorac Cancer; 2023 Mar; 14(7):662-672. PubMed ID: 36691322 [TBL] [Abstract][Full Text] [Related]
40. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior. Zhu X; Wan J; You X; Yang W; Zhao L Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]